Dustin Haines
Gilead Sciences names its new health leader for Asia markets
Gilead Sciences names its new health leader for Asia markets
Dustin Haines has 20 years leadership in pharmaceuticals.
Most Read
1. APAC nanomedicine market eyes 15% CAGR growth until 2032 2. IHH Healthcare launches ‘Global Incubator Programme’ for startups 3. Patient handling equipment market to be valued at $26.76b by 2033 4. Hong Kong moves forward with Chinese Medicine Development Blueprint 5. New regulatory regime for clinics and SPCs now in effectResource Center
Read Here
Advertise
Sign Up
Awards
Mar
26
Event News
Be recognised as one of the region’s most exceptional healthcare providers and innovators.
